Dr. Edmund (Ted) J. Sybertz '72

Dr. Sybertz received his B.S. in biology from Fairfield University in 1972. He completed a Ph.D. in pharmacology at the University of Minnesota in 1977 where he studied mechanisms by which the nervous system controls cardiovascular function. Ted then did postdoctoral training in pharmacology at the University of Virginia. From 1979-1998 he was employed at Schering Plough Research Institute and held positions of increasing responsibility in drug discovery and development and was appointed to the position of senior director and Presidential Fellow from 1995-1998. Ted was responsible for directing efforts toward the discovery of new therapies for treating cardiovascular and CNS disorders and led the research efforts that culminated in the discovery of Zetia/Vytorin, a novel and important therapy for treating hypercholesterolemia.

Ted joined GelTex Pharmaceuticals in 1998 as senior vice president of Research and Development. In 2000, GelTex merged with Genzyme Corporation, and Ted has been employed at Genzyme since then. He is currently senior vice president and general manager of Drug Discovery and Development.

Ted is the author or coauthor of over 100 scientific publications in the field of drug discovery and pharmacology. He is a member of the American Society for Pharmacology and Therapeutics. He has been active as chairman of the research committee and a member of the board of directors of the New Jersey chapter of the American Heart Association. Ted also serves on the scientific advisory board of Sirtris Pharmaceuticals.

In addition to his professional activities, Ted is an avid and active sportsman. He played ice hockey while at Fairfield and was inducted into the University's athletic hall of fame in 1987. He currently is an avid sailor and skier. Ted is married to Sharon Purdie and has two children; Sherry is a student at Wesleyan University, and Jeff is a student at Lincoln Sudbury. Ted and his family live in Sudbury, Mass.